$
29. 91
-0.25
-0.8289%
$
116.79B Market Cap
- P/E Ratio
2.7% Div Yield
139,700 Volume
- Eps
$ 30.16
Previous Close 
Want to track CSLLY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
GMAB vs. CSLLY: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Genmab A/S Sponsored ADR (GMAB) or CSL Limited Sponsored ADR (CSLLY). But which of these two stocks is more attractive to value investors?
Zacks | 2 years ago
